IP Library Granted Patent US 12,377,286
Granted Patent B2
US 12,377,286 · App. 18/424,513 · Granted Aug 5, 2025

Anti-infective and therapeutic electromagnetic emission methods and devices

Inventors: Mike Miskin (Sleepy Hollow, IL); Robert Kottritsch (Wixams, GB); Charles F. Huber (Lake Forrest, IL); Allan Brent York (Langley, CA)
Assignee: SuninLyf Bio Inc.
A61N5/0624A61N5/067G06F3/013A61N2005/0626A61N2005/0648A61N2005/0651A61N2005/0659A61N2005/0663
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,377,286
App. No.
18/424,513
Granted
Aug 5, 2025
Kind
B2
Abstract

A light emitting device for video displays with anti-infective and therapeutic electromagnetic emission methods and devices is disclosed. The light emitting device for video displays with anti-infective and therapeutic electromagnetic emission methods and devices uses non-visible and/or visible electromagnetic radiation on living species, including but not limited to people and animals, to provide treatments against infections and/or provide photobiomodulation treatments to improve health and wellness.

Claims (66)

1. An electronic device for providing photobiomodulation (“PBM”) light therapy towards a face of a person facing the electronic device, the electronic device comprising:

a housing;

at least one video display device;

at least one sensor configured to sense a distance between the electronic device and the face of the person facing the electronic device;

a first plurality of light emitters configured to receive first control signals that cause the first plurality of light emitters to emit modulated RGB wavelengths of light for producing video images on the at least one video display device; and

a second plurality of light emitters configured to receive second control signals in response to the at least one sensor sensing the distance between the electronic device and the face of the person, wherein the second control signals cause the second plurality of light emitters to emit PBM wavelengths of light at a first output energy level for a duration of time for providing PBM light therapy towards the face of the person facing the electronic device, wherein the PBM wavelengths of light emitted comprise one or more PBM wavelengths of light within a range of 600 nm to 1400 nm known to stimulate mitochondria cells in a person and cause the mitochondria cells to produce additional adenosine triphosphate (“ATP”),

wherein the second plurality of light emitters is configured to be controlled to emit the PBM wavelengths of light independent of the first plurality of light emitters being modulated and producing any video images,

wherein the second plurality of light emitters is further controlled to adjust the first output energy level or the duration of time the PBM wavelengths of light are emitted in response to changes in the distance sensed between the face of the person and the electronic device by the at least one sensor, and

wherein the second plurality of light emitters is configured to be controlled in response to an output from the at least one sensor and emit light at the first output energy level for the duration of time or a second output energy level or a second duration of time before twelve noon according to a geographical location of the electronic device.

2. The electronic device of claim 1 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light within the range of 600 nm to 1400 nm towards the face of the person facing the electronic device, wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light for a controlled period of time at a specific time of day, and wherein the controlled period of time totals at least two minutes before noon within a single day.

3. The electronic device of claim 1 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light within the range of 600 nm to 1400 nm towards the face of the person facing the electronic device, wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light for a controlled period of time at a specific time of day, and wherein the controlled period of time totals at least one consecutive minute before noon within a single day.

4. The electronic device of claim 1 , wherein the second plurality of light emitters is integrated into the at least one video display device.

5. The electronic device of claim 1 , wherein the second plurality of light emitters is integrated into the housing of the electronic device.

6. The electronic device of claim 1 , wherein the second plurality of light emitters is configured to emit two or more controlled wavelengths of light within the range of 600 nm to 1400 nm when the at least one video display device is displaying the video images.

7. The electronic device of claim 1 , wherein the second plurality of light emitters is configured to respond to the second control signals that are received in response to at least one camera integrated within the electronic device and cause the PBM wavelengths of light to be emitted through at least one optic that is configured to focus the PBM wavelengths of light onto the face of the person facing the electronic device.

8. The electronic device of claim 1 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light in response to the electronic device receiving biological information related to the person facing the electronic device, wherein the biological information is received from a remote electronic device.

9. The electronic device of claim 1 , wherein at least one of the light emitters of the second plurality of light emitters is configured to be a laser.

10. The electronic device of claim 1 , wherein the second plurality of light emitters is configured to respond to a camera integrated within the electronic device, and wherein the camera is configured to impact how the electronic device controls the second plurality of light emitters.

11. The electronic device of claim 1 , wherein at least one of the light emitters of the second plurality of light emitters is configured to emit light through an electronically controlled optic that is configured to respond to a camera, and wherein the camera is configured to impact how the electronic device controls the at least one of the light emitters.

12. The electronic device of claim 1 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light in response to the second control signals received in response to a camera detecting movement of the person facing the electronic device.

13. The electronic device of claim 1 , further comprising a camera and at least two phosphor coated LEDs configured to emit two or more color temperatures of white light,

wherein the second plurality of light emitters, the camera, and the at least two phosphor coated LEDs are configured to be independently controlled by the electronic device via a wired or a wireless connection.

14. The electronic device of claim 1 , wherein the electronic device is a wearable display.

15. An electronic device for providing photobiomodulation (“PBM”) light therapy towards a face of a person facing the electronic device, the electronic device comprising:

at least one video display device;

at least one sensor configured to sense a distance between the electronic device and the face of the person facing the electronic device;

a first plurality of light emitters configured to receive first control signals that cause the first plurality of light emitters to be modulated and emit RGB wavelengths of light for producing video images on the at least one video display device; and

a second plurality of light emitters configured to receive second control signals in response to the at least one sensor sensing the distance between the electronic device and the face of the person, wherein the second control signals cause the second plurality of light emitters to emit PBM wavelengths of light at a first output energy level for a duration of time for providing PBM light therapy towards the face of the person facing the electronic device, wherein the PBM wavelengths of light comprise one or more wavelengths of light within a range of 600 nm to 1400 nm known to stimulate mitochondria cells in a person and cause the mitochondria cells to produce additional adenosine triphosphate (“ATP”),

wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light independent of the first plurality of light emitters emitting any modulated RGB wavelengths of light used to produce the video images on the at least one video display device, and wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light towards the face of the person facing the electronic device for a total of at least one minute before twelve noon within a single day,

wherein twelve noon is determined according to a geographical location of the electronic device, and

wherein the second plurality of light emitters is further configured to be controlled in response to an output from the at least one sensor and to adjust the first output energy level or the duration of time the PBM wavelengths of light are emitted in response to changes in the distance sensed between the face of the person and the electronic device by the at least one sensor.

16. The electronic device of claim 15 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light within the range of 600 nm to 1400 nm towards the face of the person for a controlled duration of time at a specific time of day, and wherein the controlled duration of time totals at least one minute before noon within a single day.

17. The electronic device of claim 15 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light within the range of 600 nm to 1400 nm towards the face of the person for a controlled duration of time at a specific time of day in response to the electronic device receiving data wirelessly from a wearable device worn by the person facing the electronic device, and wherein the controlled duration of time totals at least one consecutive minute before noon within a single day.

18. The electronic device of claim 15 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light within the range of 600 nm to 1400 nm towards the face of the person through at least one optic that is configured to focus the PBM wavelengths of light onto the face of the person facing the electronic device while the person is viewing the video images on the at least one video display device.

19. The electronic device of claim 15 , wherein at least 5% of the first plurality of light emitters are configured to only emit red light within a range of 585 nm to 750 nm towards the face of the person for a controlled constant duration of time at a specific time of day before noon.

20. The electronic device of claim 15 , wherein the second plurality of light emitters includes micro-LEDs.

21. The electronic device of claim 15 , wherein at least one light emitter of the second plurality of light emitters is a laser.

22. The electronic device of claim 15 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light in response to the electronic device receiving biological information from a second device, wherein the biological information includes information related to the person facing the electronic device and impacts the second control signals received by the second plurality of light emitters emitting the PBM wavelengths of light.

23. The electronic device of claim 15 , wherein the electronic device is a wearable electronic device.

24. An electronic device for providing photobiomodulation (“PBM”) light therapy towards a face of a person facing the electronic device, the electronic device comprising:

a housing;

at least one video display device integrated within the housing;

at least one sensor configured to sense a distance between the electronic device and the face of the person facing the electronic device;

a first plurality of light emitters integrated within the at least one video display device and configured to be controlled to produce video images by emitting modulated RGB wavelengths of light from the at least one video display device; and

a second plurality of light emitters integrated within the electronic device and configured to emit PBM wavelengths of light towards the face of the person facing the electronic device,

wherein the PBM wavelengths of light are emitted in response to the at least one sensor sensing the distance between the electronic device and the face of the person,

wherein the PBM wavelengths of light are within a range of 600 nm to 1400 nm and emitted through at least one optic that is configured to focus the PBM wavelengths of light towards the face of the person facing the electronic device,

wherein the PBM wavelengths of light are controlled and emitted independent of the modulated RGB wavelengths of light being controlled and emitting any light for the video images,

wherein the second plurality of light emitters is controlled to emit the PBM wavelengths of light at a first energy level for a duration of time that totals at least one minute before twelve noon within a single day,

wherein twelve noon is determined according to a geographical location of the electronic device, and

wherein the second plurality of light emitters is further controlled to adjust the first energy level or the duration of time the PBM wavelengths of light are emitted in response to changes in the distance sensed between the face of the person and the electronic device.

25. The electronic device of claim 24 , wherein the second plurality of light emitters is configured to emit the PBM wavelengths of light in response to data provided to the electronic device by a device that provides biofeedback information from the person facing the electronic device, and wherein a camera is configured to impact the control of the emission of the PBM wavelengths of light in response to motion of the person facing the electronic device.

26. The electronic device of claim 24 , wherein the at least one optic is configured to have the second plurality of light emitters emit the PBM wavelengths of light, the at least one optic being dynamically controlled and configured to respond to the at least one sensor, and wherein the at least one sensor is configured to impact how the electronic device controls the at least one optic and the emission of the PBM wavelengths of light from the second plurality of light emitters.

27. The electronic device of claim 24 , wherein the second plurality of light emitters is configured to emit one or more controlled wavelengths of light within a range of 595 nm to 750 nm when the at least one video display device is displaying the video images.

28. An electronic device with a video display for providing photobiomodulation (“PBM”) light therapy, the electronic device comprising:

at least one sensor configured to sense a distance between the electronic device and a face of a person facing the electronic device; and

a plurality of RGB light emitters configured to produce video images by emitting modulated RGB wavelengths of light towards the face of the person facing the electronic device,

wherein a percentage of the plurality of RGB light emitters are configured to only emit PBM wavelengths of light within a range of 585 nm to 750 nm towards the face of the person facing the electronic device, wherein the PBM wavelengths of light are emitted at a first energy level for a duration of time before twelve noon within a single day, and wherein twelve noon is determined according to a geographical location of the electronic device,

wherein the PBM wavelengths of light being emitted at the first energy level and the duration of time are configured to be controlled to adjust at least one of (i) the first energy level of the PBM wavelengths of light, (ii) the percentage of the RGB light emitters configured to only emit the PBM wavelengths of light within the range of 585 nm to 750 nm, or (iii) the duration of time the PBM wavelengths of light are emitted, in response to changes in the distance sensed between the face of the person and the electronic device.

29. The electronic device of claim 28 , further comprising a software application configured to control:

the percentage of red light emitters emitting the PBM wavelengths of light,

which of the red light emitters are to emit the PBM wavelengths of light,

the time of day the red light emitters emit the PBM wavelengths of light,

energy levels of the red light emitters that emit the PBM wavelengths of light, and

the duration of time the red light emitters emit the PBM wavelengths of light.

30. The electronic device of claim 28 , wherein the electronic device is configured to be wearable and configured to be in wireless communication with another device.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2025
From: SUNINLYF BIO LLC
To: SUNINLYF BIO INC.
Reel/Frame 070263/0752 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2024
From: MISKIN, MIKE; KOTTRITSCH, ROBERT; HUBER, CHARLES F.; YORK, ALLAN BRENT
To: SUNINLYF BIO LLC
Reel/Frame 066841/0527 →
Continuity (6)
Provisional Application 63630055 · Dec 26, 2023
Provisional Application 63457039 · Apr 4, 2023
Provisional Application 63489139 · Mar 8, 2023
Provisional Application 63481742 · Jan 26, 2023
Related Publication 20240261591A1 · Aug 8, 2024
Related Publication 20250082962A9 · Mar 13, 2025
References Cited (189)
US 4595491A · Berns · 1986 [cited by applicant]
US 5259380A · Mendes et al. · 1993 [cited by applicant]
US 5445146A · Bellinger · 1995 [cited by applicant]
US 5500009A · Mendes et al. · 1996 [cited by applicant]
US 5766233A · Rolf · 1998 [cited by applicant]
US 5913883A · Alexander et al. · 1999 [cited by applicant]
US 6019482A · Randall · 2000 [cited by applicant]
US 6269818B1 · Harvey et al. · 2001 [cited by applicant]
US 6350275B1 · Vreman et al. · 2002 [cited by applicant]
US 6488698B1 · Hyman · 2002 [cited by applicant]
US 6673095B2 · Nordquist · 2004 [cited by applicant]
US 6875225B1 · Pederson · 2005 [cited by applicant]
US 7348736B2 · Piepgras et al. · 2008 [cited by applicant]
US 7517344B2 · Vam Hal et al. · 2009 [cited by applicant]
US 7559945B2 · Breden et al. · 2009 [cited by applicant]
US 7648649B2 · Radkov · 2010 [cited by applicant]
US 7686839B2 · Parker · 2010 [cited by applicant]
US 8506612B2 · Ashdown · 2013 [cited by applicant]
US 9079022B2 · Baird et al. · 2015 [cited by applicant]
US 9289622B2 · Feng et al. · 2016 [cited by applicant]
US 9410664B2 · Krames · 2016 [cited by applicant]
US 9415237B2 · Giovanna et al. · 2016 [cited by applicant]
US 9440090B2 · Jo et al. · 2016 [cited by applicant]
US 9526860B2 · Baaijens et al. · 2016 [cited by applicant]
US 9579521B2 · Ferraz Rigo et al. · 2017 [cited by applicant]
US 9844116B2 · Soler et al. · 2017 [cited by applicant]
US 9662067B2 · Gimenez et al. · 2017 [cited by applicant]
US 9719660B1 · Petluri et al. · 2017 [cited by applicant]
US 9808644B2 · Daffer · 2017 [cited by applicant]
US 9867255B2 · Wouter et al. · 2018 [cited by applicant]
US 9927097B2 · Lalicki et al. · 2018 [cited by applicant]
US 10009974B2 · Bremser et al. · 2018 [cited by applicant]
US 10322297B1 · Hinds et al. · 2019 [cited by applicant]
US 10357582B1 · Barron et al. · 2019 [cited by applicant]
US 10471231B2 · Moore-Ede et al. · 2019 [cited by applicant]
US 10492264B2 · Petluri et al. · 2019 [cited by applicant]
US 10632214B2 · David et al. · 2020 [cited by applicant]
US 10660182B2 · Tsubota · 2020 [cited by examiner]
US 10750591B2 · Petluri et al. · 2020 [cited by applicant]
US 10900615B2 · Krames et al. · 2021 [cited by applicant]
US 11168250B2 · Petluri et al. · 2021 [cited by applicant]
US 11198813B2 · Raghuram et al. · 2021 [cited by applicant]
US 11073727B2 · David · 2021 [cited by applicant]
US 11102863B2 · Raghuram et al. · 2021 [cited by applicant]
US 11191140B2 · Petluri et al. · 2021 [cited by applicant]
US 11198020B2 · Petluri et al. · 2021 [cited by applicant]
US 11265983B2 · Raghuram et al. · 2022 [cited by applicant]
US 11287692B1 · Pickard et al. · 2022 [cited by applicant]
US 11308849B2 · Petluri et al. · 2022 [cited by applicant]
US 11338107B2 · Allen et al. · 2022 [cited by applicant]
US 11371660B2 · Raghuram et al. · 2022 [cited by applicant]
US 11511071B2 · Krames et al. · 2022 [cited by applicant]
US 11552278B2 · Hack et al. · 2023 [cited by applicant]
US 11783748B2 · Petluri et al. · 2023 [cited by applicant]
US 20020015013A1 · Ragle · 2002 [cited by applicant]
US 20030009158A1 · Perricone · 2003 [cited by applicant]
US 20030189829A1 · Shimizu et al. · 2003 [cited by applicant]
US 20040011132A1 · Netzel · 2004 [cited by applicant]
US 20040030370A1 · Lytle · 2004 [cited by applicant]
US 20040147984A1 · Altshuler et al. · 2004 [cited by applicant]
US 20040162549A1 · Altshuler · 2004 [cited by applicant]
US 20040210277A1 · Becker et al. · 2004 [cited by applicant]
US 20040225339A1 · Yaroslavsky et al. · 2004 [cited by applicant]
US 20040230259A1 · De Matteo · 2004 [cited by applicant]
US 20050128751A1 · Roberge et al. · 2005 [cited by applicant]
US 20050177139A1 · Yamazaki et al. · 2005 [cited by applicant]
US 20050222555A1 · Manstein et al. · 2005 [cited by applicant]
US 20060009822A1 · Savage et al. · 2006 [cited by applicant]
US 20060030908A1 · Powell et al. · 2006 [cited by applicant]
US 20060200212A1 · Brawn · 2006 [cited by applicant]
US 20060217586A1 · Van Hal et al. · 2006 [cited by applicant]
US 20070027510A1 · Rodrigues et al. · 2007 [cited by applicant]
US 20070086912A1 · Dowling et al. · 2007 [cited by applicant]
US 20070115658A1 · Mueller et al. · 2007 [cited by applicant]
US 20070219605A1 · Yaroslavsky et al. · 2007 [cited by applicant]
US 20080275533A1 · Powell · 2008 [cited by applicant]
US 20090054953A1 · Whitehurst · 2009 [cited by applicant]
US 20090204185A1 · De Kok et al. · 2009 [cited by applicant]
US 20090281604A1 · Do Boer et al. · 2009 [cited by applicant]
US 20090326616A1 · Aarts et al. · 2009 [cited by applicant]
US 20100105022A1 · Kuiper et al. · 2010 [cited by applicant]
US 20100171441A1 · Schlangen et al. · 2010 [cited by applicant]
US 20100174345A1 · Ashdown · 2010 [cited by applicant]
US 20120088204A1 · Ho et al. · 2012 [cited by applicant]
US 20120095534A1 · Schlangen et al. · 2012 [cited by applicant]
US 20120253432A1 · Loveland · 2012 [cited by applicant]
US 20130147400A1 · Van Herpen et al. · 2013 [cited by applicant]
US 20130131762A1 · Oversluizen et al. · 2013 [cited by applicant]
US 20130190845A1 · Liu et al. · 2013 [cited by applicant]
US 20130218240A1 · Feng et al. · 2013 [cited by applicant]
US 20130238060A1 · Nevins · 2013 [cited by applicant]
US 20140128941A1 · Williams · 2014 [cited by applicant]
US 20140265926A1 · Hu et al. · 2014 [cited by applicant]
US 20150039060A1 · Paulussen et al. · 2015 [cited by applicant]
US 20150039061A1 · Hong et al. · 2015 [cited by applicant]
US 20150051672A1 · Jo et al. · 2015 [cited by applicant]
US 20150231408A1 · Williams et al. · 2015 [cited by applicant]
US 20150238120A1 · Shan et al. · 2015 [cited by applicant]
US 20150283399A1 · Guglielmi et al. · 2015 [cited by applicant]
US 20150343235A1 · Blanche et al. · 2015 [cited by applicant]
US 20160076736A1 · Van Bommel et al. · 2016 [cited by applicant]
US 20160116124A1 · Podowitz et al. · 2016 [cited by applicant]
US 20160317833A1 · Tedford et al. · 2016 [cited by applicant]
US 20170231058A1 · Sadwick · 2017 [cited by applicant]
US 20170361124A1 · Parker et al. · 2017 [cited by applicant]
US 20180077767A1 · Soler et al. · 2018 [cited by applicant]
US 20180092521A1 · Nolan et al. · 2018 [cited by applicant]
US 20180154172A1 · Kalmeta · 2018 [cited by applicant]
US 20180160491A1 · Biery et al. · 2018 [cited by applicant]
US 20180296851A1 · Carlin · 2018 [cited by examiner]
US 20180318599A1 · Van Bommel et al. · 2018 [cited by applicant]
US 20190167400A1 · Barnes et al. · 2019 [cited by applicant]
US 20190280717A1 · Jeong et al. · 2019 [cited by applicant]
US 20190348628A1 · Hack et al. · 2019 [cited by applicant]
US 20200092971A1 · Tsubota · 2020 [cited by examiner]
US 20200146120A1 · Petluri et al. · 2020 [cited by applicant]
US 20200260546A1 · Petluri et al. · 2020 [cited by applicant]
US 20200298016A1 · Yoon et al. · 2020 [cited by applicant]
US 20210060353A1 · Raghuram et al. · 2021 [cited by applicant]
US 20210125907A1 · Huang et al. · 2021 [cited by applicant]
US 20210136887A1 · Raghuram et al. · 2021 [cited by applicant]
US 20210227657A1 · Petluri et al. · 2021 [cited by applicant]
US 20210242182A1 · Yamakawa et al. · 2021 [cited by applicant]
US 20210251060A1 · Petluri et al. · 2021 [cited by applicant]
US 20210290973A1 · Moore-Ede et al. · 2021 [cited by applicant]
US 20210315083A1 · Harrison et al. · 2021 [cited by applicant]
US 20210338861A1 · Harrison et al. · 2021 [cited by applicant]
US 20210402210A1 · Raghuram et al. · 2021 [cited by applicant]
US 20220001200A1 · Petluri et al. · 2022 [cited by applicant]
US 20220005404A1 · Raghuram et al. · 2022 [cited by applicant]
US 20220036793A1 · Raghuram et al. · 2022 [cited by applicant]
US 20220180803A1 · Raghuram et al. · 2022 [cited by applicant]
US 20220264717A1 · Parker et al. · 2022 [cited by applicant]
US 20220272806A1 · Petluri et al. · 2022 [cited by applicant]
US 20220272820A1 · Raghuram et al. · 2022 [cited by applicant]
US 20220288412A1 · Honold et al. · 2022 [cited by applicant]
US 20220323785A1 · Petluri · 2022 [cited by examiner]
US 20220334305A1 · Harrison et al. · 2022 [cited by applicant]
US 20220404667A1 · Pickard et al. · 2022 [cited by applicant]
US 20230285771A1 · Petluri et al. · 2023 [cited by applicant]
US 20230324035A1 · Maa et al. · 2023 [cited by applicant]
AU 2021374233 · 2023 [cited by applicant]
CN 109417841 · 2019 [cited by applicant]
DE 202018005328 · 2019 [cited by applicant]
DK 2874701 · 2018 [cited by applicant]
EP 3504942 · 1990 [cited by applicant]
EP 2094064 · 2009 [cited by applicant]
EP 2164568 · 2010 [cited by applicant]
EP 2348246 · 2011 [cited by applicant]
EP 2905544 · 2015 [cited by applicant]
EP 3427660 · 2019 [cited by applicant]
EP 3668276 · 2020 [cited by applicant]
EP 4067729 · 2022 [cited by applicant]
EP 4190367 · 2023 [cited by applicant]
JP 5937016 · 2013 [cited by applicant]
JP 2020505787 · 2020 [cited by applicant]
KR 20070043085 · 2007 [cited by applicant]
KR 20070045382 · 2007 [cited by applicant]
KR 100973078 · 2010 [cited by applicant]
KR 20110081213 · 2011 [cited by applicant]
KR 20120050781 · 2012 [cited by applicant]
KR 102571122 · 2023 [cited by applicant]
KR 102571168 · 2023 [cited by applicant]
KR 102571173 · 2023 [cited by applicant]
KR 102571180 · 2023 [cited by applicant]
KR 102571189 · 2023 [cited by applicant]
KR 102571194 · 2023 [cited by applicant]
KR 102571272 · 2023 [cited by applicant]
KR 102571273 · 2023 [cited by applicant]
KR 102571274 · 2023 [cited by applicant]
KR 102571275 · 2023 [cited by applicant]
KR 102571277 · 2023 [cited by applicant]
KR 102592001 · 2023 [cited by applicant]
KR 102592005 · 2023 [cited by applicant]
SU 155992 · 1985 [cited by applicant]
WO 9000458 · 1990 [cited by applicant]
WO 2008069101 · 2010 [cited by applicant]
WO 2012021243 · 2012 [cited by applicant]
WO 2015184019 · 2015 [cited by applicant]
WO 2016037994 · 2016 [cited by applicant]
WO 2016146688 · 2016 [cited by applicant]
WO 2017210461 · 2017 [cited by applicant]
WO 2016208683 · 2018 [cited by applicant]
WO 2018130403 · 2018 [cited by applicant]
WO 2019139635 · 2019 [cited by applicant]
WO 2019140306 · 2019 [cited by applicant]
WO 2020097575 · 2020 [cited by applicant]
WO 2022200131 · 2022 [cited by applicant]
European Office Action—Application No. 21792152.7 dated Mar. 22, 2024—9 pages. [cited by applicant]